Addiction treatment provider BrightView Health is deepening its footprint in Virginia with the acquisition of Virginia Beach-based Right Path Addiction Treatment Centers.
Right Path operates five clinics in eastern Virginia, which are located in Richmond, Chesapeake, Newport News, Suffolk and its homebase of Virginia Beach. The provider offers medication-assisted treatment (MAT) drugs such as buprenorphine and naltrexone to treat substance use disorders (SUDs) like opioid and alcohol addiction, and are provided in conjunction with other services including psychotherapy.
Right Path accepts a number of commercial insurances as well as Medicaid, Medicare and Tricare, which is the U.S. Department of Defense’s payer plan for active and retired military personnel.
“Partnering with BrightView enables us to serve more patients, leverage economies of scale, and expand our offering,” John Delaney, the co-founder and CEO of Right Path, said in a press release about the deal.
Headquartered in Cincinnati, BrightView operates over 40 locations throughout Virginia, Ohio, Kentucky and Delaware.
BrightView’s programs include MAT, individual counseling, group therapy and social service support. Similar to Right Path, BrightView accepts a number of commercial insurances, Medicaid and Medicare.
“Right Path has had a profound impact on thousands of patients and their communities,” BrightView Health Chief Development Officer Dylan Jackson said in the press release. “We are excited to build on their legacy of quality, accessible care.”
All services at Right Path will continue uninterrupted, with plans for all of its staff to make the transition to BrightView, according to Jackson.
“We understand the importance of evidence-based treatment, and we are committed to ensuring a smooth transition for each patient, staff member, and community partner,” Jackson added in the release. “The team at BrightView is looking forward to bringing our expertise and leadership in the field to the communities Right Path serves.”
BrightView is backed by health care-focused private equity firm Shore Capital Partners.
Terms of the deal were not announced.